Fierce Pharma Asia—Legend, J&J’s CAR-T delay; BeiGene’s Brukinsa data; Samsung Biologics CEO interview

Fierce Pharma Asia—Legend, J&J’s CAR-T delay; BeiGene’s Brukinsa data; Samsung Biologics CEO interview
aliu
Fri, 11/05/2021 – 06:24